Skip to main content

Latest Technology Finance Web3

Markets

01 / CREDITCredit RadarTreasury curves, stress indexes, auctions, and corporate credit events and debt issuance from SEC filings.02 / PREDICTIONPrediction market boardPolymarket prices for markets Nvdium monitors. Prices are not facts or probability guarantees.03 / ON-CHAINWhale RadarLarge on-chain flows and signals, with backtests and sources.04 / EARNINGSEarnings calendarEarnings dates across major markets with watchlists.

Every data point carries its source and observation date.All market desks ↗

Search

Home Latest Technology Finance Web3 Markets

Loading article

NEWSLETTER

Get the signals worth reading in your inbox

Email address

By subscribing, you agree to our privacy policy.

NvdiumMake valuable technology information easier to discover.[email protected]© 2026 Nvdium

About Copyright PrivacyComplaints RSS

To keep drug prices high, pharma has been piling up the… · Nvdium

←Back to feed

Home/Technology/Article

To keep drug prices high, pharma has been piling up the patents

BBeth Mole·Ars TechnicaPublished Sep 29, 2026, 04:32 AM

What happened

Add-on patents have increased drug patent periods from two years to over six.

Was this useful?

Read original↗

Share this article

Copyright belongs to the original author and source. Nvdium provides aggregation and reading navigation only.

Go deeper

Claude Renames Max 20x to Ultra, Drops 5-Hour Cap for Verified Users
Mento VC's SAB: AI Aces Startup Research, Fails Growth Prediction
Voice Arena's Turing TTS: Best AI Voice Fools Listeners 10.5%
Apple Intelligence Comes to China in iOS 27.3, With Alibaba's Qwen
Google's Suncatcher Satellite Runs First AI Inference in Orbit
Anthropic Lets Claude Red-Team Its Own Training-Data Monitors